Comparing the Efficacy of Bricanyl M2 and Bricanyl M3 at 0.5 and 1.5 mg Dose Levels, to Allow for a Switch From Bricanyl Turbuhaler M2 to Bricanyl Turbuhaler M3
Clinical trial NCT02322788 · COMPLETED
Trial details
- NCT number
- NCT02322788
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2015-11-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.